Memantine hydrochloride is a medication used to treat moderate to severe Alzheimer's disease. It works by blocking the effects of glutamate, a neurotransmitter that can overstimulate brain cells and contribute to Alzheimer's symptoms.
How does memantine hydrochloride work for Alzheimer's?
Memantine hydrochloride functions as an N-methyl-D-aspartate (NMDA) receptor antagonist [1]. By selectively blocking NMDA receptors, it prevents excessive stimulation of brain cells by glutamate. This mechanism is believed to help protect neurons from damage and improve cognitive function in individuals with Alzheimer's disease [1].
What are the common dosages for memantine hydrochloride?
The typical starting dose for memantine hydrochloride is 5 mg once daily [2]. This dose is usually increased incrementally, with the target maintenance dose being 10 mg twice daily, for a total daily dose of 20 mg [2]. Dosing adjustments are often made over a period of weeks to allow the body to adjust to the medication.
When does the patent for memantine hydrochloride expire?
The patent protection for memantine hydrochloride, marketed under the brand name Namenda, has largely expired in major markets. For example, U.S. patents for the immediate-release formulation expired around 2012-2013 [3]. Extended-release formulations may have had later patent expiries, but generic versions are now widely available. Information on specific patent expiry dates for various formulations and regions can be found on sites like DrugPatentWatch.com [3].
What are the side effects of memantine hydrochloride?
Common side effects associated with memantine hydrochloride include dizziness, headache, confusion, drowsiness, and constipation [1]. Less common but more serious side effects can occur, and patients should report any unusual symptoms to their healthcare provider.
What are the alternatives to memantine hydrochloride?
Other medications used to treat Alzheimer's disease include cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine [4]. These drugs work by increasing the levels of acetylcholine, another neurotransmitter involved in memory and learning. The choice of treatment depends on the stage of the disease and individual patient factors.
Can generic versions of memantine hydrochloride be used?
Yes, due to patent expiries, generic versions of memantine hydrochloride are available and are often more affordable than the brand-name drug [3]. These generic formulations are approved by regulatory agencies and are considered therapeutically equivalent to the brand-name product.
What is the clinical data supporting memantine hydrochloride's use?
Clinical trials have demonstrated that memantine hydrochloride can help improve cognitive function and slow the decline of daily living activities in patients with moderate to severe Alzheimer's disease [1]. Studies have shown statistically significant benefits in areas such as memory, attention, and global functioning compared to placebo.
Who manufactures memantine hydrochloride?
The original brand-name drug, Namenda, was developed by Forest Laboratories (now part of AbbVie). Numerous pharmaceutical companies now manufacture generic versions of memantine hydrochloride.